Position history for MARSHALL WACE, LLP's holdings in REGENERON PHARMACEUTICALS
MARSHALL WACE, LLP holds 478,551 shares of REGN (REGENERON PHARMACEUTICALS), worth $369.4M as of 2025-Q4. The position was increased (++23.7% shares). REGN represents 0.3% of MARSHALL WACE, LLP's portfolio.
Current Value
$369.4M
Current Shares
478,551
Total Value Change
+$307.5M
Total Shares Change
+419,678
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 478,551 |
+23.7% |
| $369.4M |
| 0.3% |
| $773.94 |
45 |
| 2025-Q3 | Increased | 386,884 | +61.3% | $217.5M | 0.2% | $560.05 | 53 |
| 2025-Q2 | Increased | 239,909 | +170x | $126M | 0.1% | $519.56 | 58 |
| 2025-Q1 | Decreased | 1,400 | -98.9% | $887,922 | 0.0% | $634.66 | 0 |
| 2024-Q4 | Decreased | 127,400 | -4.9% | $90.8M | 0.1% | $698.71 | 0 |
| 2024-Q3 | Increased | 134,004 | +127.6% | $140.9M | 0.2% | $1,036.94 | 58 |
| 2024-Q2 | Decreased | 58,873 | -70.6% | $61.9M | 0.1% | $1,045.23 | 0 |